RxSight Inc

Research RxSight Inc (RXST) on Bullrun: market cap USD 211.12M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRXST
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 211.12M
• Financial periodFY2025
• RevenueUSD 134.48M
• Revenue growth-3.9%
• Net income-USD 39
• Free cash flow-USD 19.34M
• Gross margin76.6%

Valuation Snapshot

latest market cap is USD 211.12M.

About RxSight Inc

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.

Frequently asked questions

What is RxSight Inc's market cap?

RxSight Inc's market capitalization is USD 211.12M.

What does RxSight Inc do?

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.